ITM2B amyloidosis | Kisho | Kisho

ITM2B amyloidosis

Rare Disease

MONDO:0018591

Also known as:

ITM2B-related amyloidosisITM2B-related cerebral amyloid angiopathyfamilial cerebral amyloid angiopathy

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Feb 7, 2026

Associated Genes

1 gene

ITM2B

Gene data from HGNC • Click to view on NCBI Gene

Associated Genes

1 gene

ITM2B

Gene data from HGNC • Click to view on NCBI Gene

Overview

ITM2B amyloidosis is a rare condition that is also known by several other names including ITM2B-related amyloidosis, ITM2B-related cerebral amyloid angiopathy, and familial cerebral amyloid angiopathy. Detailed definition information is not available from the current trusted sources, so the full spectrum of its features is still being researched. This condition is recognized as one of the rare forms of amyloidosis, where abnormal protein deposits may occur in tissues. Because the scientific and medical communities are still working to understand ITM2B amyloidosis, information about how it develops and affects people remains limited. People with this condition and their families may find it helpful to stay updated through reliable medical resources as further research clarifies the nature of the disease.

Symptoms & Signs

Information about symptoms is currently limited for this condition.

Causes & Risk Factors

Information about causes is currently limited for this condition.

Treatment & Management

Information about treatment is currently limited for this condition.

Prognosis & Outlook

Information about prognosis is currently limited for this condition.

Research & Clinical Trials

Information about current research is currently limited for this condition.

Quick Resources

Helpful links for rare disease information and support

GARD (Genetic and Rare Diseases Information Center)NORD (National Organization for Rare Disorders)Find a Genetic Counselor

General Questions to Consider

Questions that may be helpful when speaking with your healthcare team

•Are there specialists or centers of excellence with experience in this condition?
•Is there a patient registry I could participate in?
•Should my family members consider genetic testing?
•What clinical trials might be available for this condition?
•Are there patient advocacy groups I should connect with?

Clinical

Associated Genes

1 gene

ITM2B

Gene data from HGNC • Click to view on NCBI Gene

Treatment

Support

External Resources

Orphanet

European rare disease database

Orphanet:439254

GARD

Genetic and Rare Diseases Info Center

GARD:17741

Know a Patient Advocacy Group for this condition?

Help patients and families find support by registering your organization or suggesting a group that serves this community.

Was this helpful?

AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases

ITM2B amyloidosis

Patient-Friendly Information

Associated Genes

Associated Genes

Overview

Overview

Symptoms & Signs

Causes & Risk Factors

Treatment & Management

Prognosis & Outlook

Research & Clinical Trials

Quick Resources

General Questions to Consider

Clinical

Associated Genes

Treatment

Support

External Resources

Orphanet

GARD

Related Diseases

Know a Patient Advocacy Group for this condition?

Need this data in your product?